A 58-year-old woman on mechanical ventilation in the ICU develops fever (39.2°C), purulent endotracheal secretions, and a new infiltrate on chest X-ray on day 5 of hospitalization. Blood cultures are pending. What is the empiric drug of choice for hospital-acquired pneumonia in this patient?

Explanation

## Empiric Treatment of Hospital-Acquired Pneumonia (HAP) **Key Point:** Empiric coverage for HAP must include broad-spectrum agents targeting gram-negative organisms (including *Pseudomonas aeruginosa*), gram-positive cocci (including methicillin-resistant *Staphylococcus aureus* [MRSA] if risk factors present), and anaerobes. Piperacillin-tazobactam or a carbapenem ± vancomycin is standard. ### Pathogen Profile in HAP | Organism | Frequency | Risk Factors | |----------|-----------|---------------| | *Pseudomonas aeruginosa* | 25–40% | Prolonged ventilation, prior antibiotics | | *Staphylococcus aureus* (including MRSA) | 15–30% | Recent hospitalization, ICU stay | | *Enterobacteriaceae* (*E. coli*, *Klebsiella*) | 20–30% | Aspiration risk, GI colonization | | Anaerobes | 10–15% | Aspiration, poor oral hygiene | ### Recommended Empiric Regimens **First-line options:** 1. **Piperacillin-tazobactam** 4.5 g IV every 6–8 hours - Covers *Pseudomonas*, gram-negatives, and anaerobes - Does NOT cover MRSA — add vancomycin if MRSA risk is high 2. **Carbapenem** (meropenem 1 g IV every 8 hours OR imipenem 500 mg IV every 6 hours) - Broad spectrum; excellent for resistant gram-negatives - Does NOT cover MRSA — add vancomycin if MRSA risk is high **Addition of Vancomycin:** - Add if: MRSA colonization, prior MRSA infection, high local prevalence, or clinical deterioration - Dosing: Vancomycin 15–20 mg/kg IV every 8–12 hours (target trough 15–20 μg/mL) **High-Yield:** HAP occurring after 5+ days of hospitalization is at high risk for multidrug-resistant (MDR) pathogens. Monotherapy with cephalosporins or fluoroquinolones is inadequate. **Clinical Pearl:** Always obtain lower respiratory tract cultures (endotracheal aspirate or bronchoalveolar lavage) before starting antibiotics. De-escalate based on culture results and clinical response at 48–72 hours. **Mnemonic for HAP Pathogens:** **PEGS** — *Pseudomonas*, *Enterobacteriaceae*, Gram-positive cocci (MRSA), anaerobes (Staph, anaerobes). [cite:Harrison 21e Ch 297]